VN

Venkata Nageswara Rao Cherukuri

Director Director DIN 03523480
DIN 03523480 First appointment Jul 2011 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jul 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Nageswara Rao Cherukuri

Data last updated:

Venkata Nageswara Rao Cherukuri was a Director at Chantilly Bio Pharma Private Limited (2011–2016). The company operates in Research & Development.

DIN 03523480
Primary Designation Director
Industry Research & Development
First Appointment 04 Jul 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chantilly Bio Pharma Private Limited U74999TG2011PTC075331
Director04 Jul 20112011₹49 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chantilly Bio Pharma Private Limited
Premium access

Shareholding and investment profile for Venkata Nageswara Rao Cherukuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Nageswara Rao Cherukuri

Venkata Nageswara Rao Cherukuri was first appointed on 04 Jul 2011 as Director at Chantilly Bio Pharma Private Limited.

Venkata Nageswara Rao Cherukuri held 1 earlier board appointment: Chantilly Bio Pharma Private Limited (Director, 04 Jul 2011 to 23 Jan 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available